Características clínico-epidemiológicas y evolución del tratamiento en pacientes con úlceras corneales

Ku Lozano, Jenny; Samudio, Margarita; Penniecook-Sawyers, Jason A; Abente, Sonia; Duré, Carolina.
Mem. Inst. Invest. Cienc. Salud (Impr.) ; 17(1): 16-24, abr. 2019. tab
Artículo en Español | LILACS, PARAGUAY | ID: biblio-1007865

Similares

  1. Fungal Keratitis Caused by Talaromyces coalescens: A Case Report.
  2. In vitro antifungal susceptibility of Fusarium species and Aspergillus fumigatus cultured from eleven horses with fungal keratitis.
  3. Clinical and microbiological analysis of fungal keratitis in Toronto, Canada: A 20-year study.
  4. Biophilic Positive Carbon Dot Exerts Antifungal Activity and Augments Corneal Permeation for Fungal Keratitis.
  5. Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.
  6. Clinical Profile and Treatment Outcomes of Patients With Acremonium Species Positive Keratitis Managed in a Tertiary Eye Care Center.
  7. Therapy for contact lens-related ulcers.
  8. Six-year analysis of the pathogenic spectrum, risk factors, and prognosis of non-traumatic fungal keratitis in Northern China.
  9. Effect of pretreatment with antifungal agents on clinical outcomes in fungal keratitis.
  10. Continuous voriconazole lavage in managing moderate and severe fungal keratitis: a randomized controlled trial.